| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |